Mr. Mutkoski represents publicly and privately held corporations in a variety of industries including software, hardware, communications, education, life sciences and information technology services. He also represents investment banks, private equity firms and venture capital funds in connection with private investments and public offerings in those industries.
Publicly held companies represented by Mr. Mutkoski have included Monotype Imaging Holdings Inc., CIFC Corp., Phase Forward Incorporated, Albany Molecular Research, Inc., The Princeton Review, Inc., Candela Corporation, Animal Health International, Inc., Metabolix, Inc. and Concerto Software, Inc. (formerly Davox Corporation). He has also counseled numerous investment banks in connection with underwritten public offerings for such companies as Netezza, Accent Color Sciences, Idexx Laboratories, Metrika Systems, National Dentex, Number 9 Visual Technology, Philip Services, Thermedics Detection, Thermo Optek, Thermo Vision and Trident International.
Mr. Mutkoski's extensive experience in mergers and acquisitions includes PhaseForward’s merger with Oracle; Monotype’s acquisitions of Bitstream, Ascender, Fontcommerce, Design by Front and PlanetWeb; The Princeton Review's acquisitions of Penn Foster Education Group and numerous other companies, and the sale of its K-12 division to Core Education and its Test Prep division to Charlesbank; Phase Forward's acquisitions of Maaguzi, Waban Software, Clarix, Clinsoft, Lincoln Technologies and Green Mountain Logic; Candela Corporation's merger with Syneron Medical Ltd.; HealthMedia's sale to Johnson & Johnson; Direct Hit's sale to Ask Jeeves; Concerto Software's merger with Melita International; Numara Software's acquisitions of Unipress Software and Criston Software; netNumina's sale to Keane; and Concerto Software's acquisitions of Cellit and Answersoft.
Mr. Mutkoski also represents private equity and venture capital firms in connection with their portfolio investments in operating companies.